Amarin Corp Plcuk (AMRN) Cash & Equivalents (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cash & Equivalents of $201000.0 for Q1 2026, down 33.0% YoY from $300000.0 in Q1 2025, and down 99.85% sequentially from $134.7 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Cash & Equivalents (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cash & Equivalents across 17 years of filings, most recently posting $201000.0 for Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 33.0% year-over-year to $201000.0; the TTM figure through Mar 2026 stood at $201000.0 (down 33.0% YoY), while the FY2025 annual figure was $134.7 million, up 44786.67% from the prior year.
  • Cash & Equivalents slipped to $201000.0 in Q1 2026, from $134.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AMRN reached as high as $228.0 million in Q2 2022 and fell as low as $201000.0 in Q1 2026.
  • The 5-year median for Cash & Equivalents is $525000.0 (2023), against an average of $76.6 million.
  • The widest YoY moves for Cash & Equivalents: up 44786.67% in 2025, down 99.81% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $523000.0 in 2022, then advanced by 0.38% to $525000.0 in 2023, then sank by 42.86% to $300000.0 in 2024, then surged by 44786.67% to $134.7 million in 2025, then tumbled by 99.85% to $201000.0 in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $201000.0, $134.7 million, and $301000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 21.69 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 9.39 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.56 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 5.33 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 7.63 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.70 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 201,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 201,000.00
Dec 31, 2025 134.66 Mn
Sep 30, 2025 301,000.00
Jun 30, 2025 147.90 Mn
Mar 31, 2025 300,000.00
Dec 31, 2024 300,000.00
Sep 30, 2024 156.90 Mn
Jun 30, 2024 215.90 Mn
Mar 31, 2024 525,000.00
Dec 31, 2023 525,000.00
Sep 30, 2023 524,000.00
Jun 30, 2023 524,000.00
Mar 31, 2023 191.41 Mn
Dec 31, 2022 523,000.00
Sep 30, 2022 3.92 Mn
Jun 30, 2022 228.00 Mn
Mar 31, 2022 219.20 Mn
Dec 31, 2021 219.45 Mn
Sep 30, 2021 222.90 Mn
Jun 30, 2021 3.92 Mn